Those patients with WHO cytogenetic subtypes (i.e., MLL rearrangements, ploidies, Burkitt ALL), with other hemopathies, or with BCP-ALL with incomplete follow-up data were excluded. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.